Morris, M. J., Hilden, P., Gleave, M. E., Armstrong, A. J., Carducci, M. A., Saad, F., … Scher, H. I. (2015). Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy. In Journal of Clinical Oncology (Vol. 33, pp. 5011–5011). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.5011

Morris, Michael J., Patrick Hilden, Martin Edwin Gleave, Andrew J. Armstrong, Michael Anthony Carducci, Fred Saad, Erica Simone Dayan, et al. “Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy.” In Journal of Clinical Oncology, 33:5011–5011. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.5011.

Morris MJ, Hilden P, Gleave ME, Armstrong AJ, Carducci MA, Saad F, et al. Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 5011–5011.

Morris, Michael J., et al. “Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 5011–5011. Crossref, doi:10.1200/jco.2015.33.15_suppl.5011.

Morris MJ, Hilden P, Gleave ME, Armstrong AJ, Carducci MA, Saad F, Dayan ES, Filipenko J, Acosta I, Heller G, Scher HI. Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 5011–5011.